article thumbnail

Global Sequencing Reagents Market (2021 to 2028) – Featuring Agilent Technologies, BGI Genomics and Qiagen Among Others – ResearchAndMarkets.com

BioTech 365

Global Sequencing Reagents Market (2021 to 2028) – Featuring Agilent Technologies, BGI Genomics and Qiagen Among Others – ResearchAndMarkets.com Global Sequencing Reagents Market (2021 to 2028) – Featuring Agilent Technologies, BGI Genomics and Qiagen Among Others – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)

Reagent 40
article thumbnail

Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome

BioTech 365

Reagent Kit. Reagent Kits aim to make whole genome sequencing more accessible and affordable for labs … Continue reading → SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. Nasdaq:ILMN). The power to make bigger discoveries is here with the launch of NovaSeqTM 6000 v1.5 The new NovaSeq6000 v1.5

Reagent 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Up to 8 recipients to be awarded grants for genomic research

Drug Discovery World

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . The post Up to 8 recipients to be awarded grants for genomic research appeared first on Drug Discovery World (DDW).

Genome 52
article thumbnail

Partners working to realise the future of genomic medicine

Drug Discovery World

The post Partners working to realise the future of genomic medicine appeared first on Drug Discovery World (DDW).

Genome 52
article thumbnail

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering DUBLIN & TOKYO–(BUSINESS WIRE)–ERS Genomics Limited, which was formed to provide broad … Continue reading →

Genome 52
article thumbnail

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

article thumbnail

 ERS Genomics Announces Agreement with FASMAC to Commercialize CRISPR/Cas9 Research Reagents in Japan

BioTech 365

Food analysis and biotechnology company licenses gene editing technology DUBLIN & KANAGAWA, Japan–(BUSINESS WIRE)–ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has … Continue (..)

Genome 52